Abstract:Ferroptosis, a form of regulated cell death that is induced by excessive lipid peroxidation, is a key tumour suppression mechanism<a href="#ref-CR1">1</a>,<a href="#ref-CR2">2</a>,<a href="#ref-CR3">3</a>,<a href="/articles/s41586-021-03539-7#ref-CR4">4</a>. Glutathione peroxidase 4 (GPX4)<a href="/articles/s41586-021-03539-7#ref-CR5">5</a>,<a href="/articles/s41586-021-03539-7#ref-CR6">6</a> and ferroptosis suppressor protein 1 (FSP1)<a href="/articles/s41586-021-03539-7#ref-CR7">7</a>,<a href="/articles/s41586-021-03539-7#ref-CR8">8</a> constitute two major ferroptosis defence systems. Here we show that treatment of cancer cells with GPX4 inhibitors results in acute depletion of N-carbamoyl-l-aspartate, a pyrimidine biosynthesis intermediate, with concomitant accumulation of uridine. Supplementation with dihydroorotate or orotate—the substrate and product of dihydroorotate dehydrogenase (DHODH)—attenuates or potentiates ferroptosis induced by inhibition of GPX4, respectively, and these effects are particularly pronounced in cancer cells with low expression of GPX4 (GPX4low). Inactivation of DHODH induces extensive mitochondrial lipid peroxidation and ferroptosis in GPX4low cancer cells, and synergizes with ferroptosis inducers to induce these effects in GPX4high cancer cells. Mechanistically, DHODH operates in parallel to mitochondrial GPX4 (but independently of cytosolic GPX4 or FSP1) to inhibit ferroptosis in the mitochondrial inner membrane by reducing ubiquinone to ubiquinol (a radical-trapping antioxidant with anti-ferroptosis activity). The DHODH inhibitor brequinar selectively suppresses GPX4low tumour growth by inducing ferroptosis, whereas combined treatment with brequinar and sulfasalazine, an FDA-approved drug with ferroptosis-inducing activity, synergistically induces ferroptosis and suppresses GPX4high tumour growth. Our results identify a DHODH-mediated ferroptosis defence mechanism in mitochondria and suggest a therapeutic strategy of targeting ferroptosis in cancer treatment.

Discovery and optimization of indirubin derivatives as novel ferroptosis inducers for the treatment of colon cancer

Discovery of a Potent Chloroacetamide GPX4 Inhibitor with Bioavailability to Enable Target Engagement in Mice, a Potential Tool Compound for Inducing Ferroptosis in Vivo.

A Chiral Fluorescent Ir(iii) Complex That Targets the GPX4 and ErbB Pathways to Induce Cellular Ferroptosis.

Honokiol Induces Ferroptosis In Colon Cancer Cells By Regulating Gpx4 Activity

Discovery of novel urea derivatives as ferroptosis and autophagy inducer for human colon cancer treatment

Discovery of Novel Potent Covalent Glutathione Peroxidase 4 Inhibitors as Highly Selective Ferroptosis Inducers for the Treatment of Triple-Negative Breast Cancer

ZX703: A Small-Molecule Degrader of GPX4 Inducing Ferroptosis in Human Cancer Cells

ML162 derivatives incorporating a naphthoquinone unit as ferroptosis/apoptosis inducers: Design, synthesis, anti-cancer activity, and drug-resistance reversal evaluation

Discovery of ML210-Based glutathione peroxidase 4 (GPX4) degrader inducing ferroptosis of human cancer cells

Identification of a ferritinophagy inducer via sinomenine modification for the treatment of colorectal cancer

How Does Ferrocene Correlate with Ferroptosis? Multiple Approaches to Explore Ferrocene-Appended GPX4 Inhibitors as Anticancer Agents

Pt3R5G Inhibits Colon Cancer Cell Proliferation Through Inducing Ferroptosis by Down-Regulating SLC7A11.

Discovery of 4-hydroxyl pyrazole derivatives as potent ferroptosis inhibitors

A potent GPX4 degrader to induce ferroptosis in HT1080 cells

Design, Synthesis, and Biological Evaluation for First GPX4 and CDK Dual Inhibitors

Recent Progress of Glutathione Peroxidase 4 Inhibitors in Cancer Therapy

Advancing the frontiers of colorectal cancer treatment: harnessing ferroptosis regulation

DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer

A novel microtubule inhibitor promotes tumor ferroptosis by attenuating SLC7A11/GPX4 signaling

Identification of a new small molecule that initiates ferroptosis in cancer cells by inhibiting the system Xc<SUP>-</SUP> to deplete GSH

A Potent and Selective Anti-Glutathione Peroxidase 4 Nanobody as Ferroptosis Inducer